AboutSign In

IMCODE003

Event

Phase 2 clinical trial of autogene cevumeran in resected pancreatic cancer, enrolling approximately 260 patients

1 story

01
health3h ago

Personalized Cancer Vaccine Shows Sustained Survival Benefit Six Years After Treatment

10 min read